Global Rabies Vaccine for Humans Supply, Demand and Key Producers, 2023-2029

Description

Rabies Vaccine is an immunization drug used to prevent rabies in people who have been bitten by an animal or otherwise exposed to the rabies virus.

There are a number of rabies vaccines available that are both safe and effective. They can be used to prevent rabies, before or after exposure to the rabies virus, which is commonly caused by a dog bite or a bat bite.

This report studies the global Rabies Vaccine for Humans production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Rabies Vaccine for Humans, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Rabies Vaccine for Humans that contribute to its increasing demand across many markets.

The global Rabies Vaccine for Humans market size is expected to reach $ 1362.2 million by 2029, rising at a market growth of 3.3% CAGR during the forecast period (2023-2029).

Global Human Rabies Vaccine market leaders include Chengda Bio, Bharat Biotech, Bavarian Nordic, Sanofi-Pasteur, etc. All of the above hold over 65 percent market share.

Asia-Pacific is the largest consumption area, with a consumption market share close to 60%. Besides, North Americas is the second largest consumption area with a consumption market share of over 15%.

The classification of Human Rabies Vaccine includes Vero Cell, BHK, Chick Embryo Cell, Human Diploid Cells, and Others. In addition, the proportion of Vero Cell rabies vaccines is about 85%.

Human Rabies Vaccine is widely used for Pre-exposure and Post-exposure. The segment of Human Rabies Vaccine used for Post-exposure and the market share is over 71% of the share.

Highlights and key features of the study
Global Rabies Vaccine for Humans total production and demand, 2018-2029, (K Units)
Global Rabies Vaccine for Humans total production value, 2018-2029, (USD Million)
Global Rabies Vaccine for Humans production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Rabies Vaccine for Humans consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Rabies Vaccine for Humans domestic production, consumption, key domestic manufacturers and share
Global Rabies Vaccine for Humans production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Rabies Vaccine for Humans production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Rabies Vaccine for Humans production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Rabies Vaccine for Humans market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novartis, Sanofi, GlaxoSmithKline, Merck, Chengda, Yisheng, Prcmise, VACN and Changsheng, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Rabies Vaccine for Humans market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (USD/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Rabies Vaccine for Humans Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Rabies Vaccine for Humans Market, Segmentation by Type
    Preventative Vaccine
    Emergency Rabies Vaccine

Global Rabies Vaccine for Humans Market, Segmentation by Application
    Pre-exposure prophylaxis
    Post-exposure prophylaxis

Companies Profiled:
    Novartis
    Sanofi
    GlaxoSmithKline
    Merck
    Chengda
    Yisheng
    Prcmise
    VACN
    Changsheng
    BCHT
    Hissen

Key Questions Answered
1. How big is the global Rabies Vaccine for Humans market?
2. What is the demand of the global Rabies Vaccine for Humans market?
3. What is the year over year growth of the global Rabies Vaccine for Humans market?
4. What is the production and production value of the global Rabies Vaccine for Humans market?
5. Who are the key producers in the global Rabies Vaccine for Humans market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Rabies Vaccine for Humans Introduction
    1.2 World Rabies Vaccine for Humans Supply & Forecast
        1.2.1 World Rabies Vaccine for Humans Production Value (2018 & 2022 & 2029)
        1.2.2 World Rabies Vaccine for Humans Production (2018-2029)
        1.2.3 World Rabies Vaccine for Humans Pricing Trends (2018-2029)
    1.3 World Rabies Vaccine for Humans Production by Region (Based on Production Site)
        1.3.1 World Rabies Vaccine for Humans Production Value by Region (2018-2029)
        1.3.2 World Rabies Vaccine for Humans Production by Region (2018-2029)
        1.3.3 World Rabies Vaccine for Humans Average Price by Region (2018-2029)
        1.3.4 North America Rabies Vaccine for Humans Production (2018-2029)
        1.3.5 Europe Rabies Vaccine for Humans Production (2018-2029)
        1.3.6 China Rabies Vaccine for Humans Production (2018-2029)
        1.3.7 Japan Rabies Vaccine for Humans Production (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Rabies Vaccine for Humans Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Rabies Vaccine for Humans Major Market Trends
    1.5 Influence of COVID-19 and Russia-Ukraine War
        1.5.1 Influence of COVID-19
        1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
    2.1 World Rabies Vaccine for Humans Demand (2018-2029)
    2.2 World Rabies Vaccine for Humans Consumption by Region
        2.2.1 World Rabies Vaccine for Humans Consumption by Region (2018-2023)
        2.2.2 World Rabies Vaccine for Humans Consumption Forecast by Region (2024-2029)
    2.3 United States Rabies Vaccine for Humans Consumption (2018-2029)
    2.4 China Rabies Vaccine for Humans Consumption (2018-2029)
    2.5 Europe Rabies Vaccine for Humans Consumption (2018-2029)
    2.6 Japan Rabies Vaccine for Humans Consumption (2018-2029)
    2.7 South Korea Rabies Vaccine for Humans Consumption (2018-2029)
    2.8 ASEAN Rabies Vaccine for Humans Consumption (2018-2029)
    2.9 India Rabies Vaccine for Humans Consumption (2018-2029)

3 World Rabies Vaccine for Humans Manufacturers Competitive Analysis
    3.1 World Rabies Vaccine for Humans Production Value by Manufacturer (2018-2023)
    3.2 World Rabies Vaccine for Humans Production by Manufacturer (2018-2023)
    3.3 World Rabies Vaccine for Humans Average Price by Manufacturer (2018-2023)
    3.4 Rabies Vaccine for Humans Company Evaluation Quadrant
    3.5 Industry Rank and Concentration Rate (CR)
        3.5.1 Global Rabies Vaccine for Humans Industry Rank of Major Manufacturers
        3.5.2 Global Concentration Ratios (CR4) for Rabies Vaccine for Humans in 2022
        3.5.3 Global Concentration Ratios (CR8) for Rabies Vaccine for Humans in 2022
    3.6 Rabies Vaccine for Humans Market: Overall Company Footprint Analysis
        3.6.1 Rabies Vaccine for Humans Market: Region Footprint
        3.6.2 Rabies Vaccine for Humans Market: Company Product Type Footprint
        3.6.3 Rabies Vaccine for Humans Market: Company Product Application Footprint
    3.7 Competitive Environment
        3.7.1 Historical Structure of the Industry
        3.7.2 Barriers of Market Entry
        3.7.3 Factors of Competition
    3.8 New Entrant and Capacity Expansion Plans
    3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
    4.1 United States VS China: Rabies Vaccine for Humans Production Value Comparison
        4.1.1 United States VS China: Rabies Vaccine for Humans Production Value Comparison (2018 & 2022 & 2029)
        4.1.2 United States VS China: Rabies Vaccine for Humans Production Value Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States VS China: Rabies Vaccine for Humans Production Comparison
        4.2.1 United States VS China: Rabies Vaccine for Humans Production Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: Rabies Vaccine for Humans Production Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States VS China: Rabies Vaccine for Humans Consumption Comparison
        4.3.1 United States VS China: Rabies Vaccine for Humans Consumption Comparison (2018 & 2022 & 2029)
        4.3.2 United States VS China: Rabies Vaccine for Humans Consumption Market Share Comparison (2018 & 2022 & 2029)
    4.4 United States Based Rabies Vaccine for Humans Manufacturers and Market Share, 2018-2023
        4.4.1 United States Based Rabies Vaccine for Humans Manufacturers, Headquarters and Production Site (States, Country)
        4.4.2 United States Based Manufacturers Rabies Vaccine for Humans Production Value (2018-2023)
        4.4.3 United States Based Manufacturers Rabies Vaccine for Humans Production (2018-2023)
    4.5 China Based Rabies Vaccine for Humans Manufacturers and Market Share
        4.5.1 China Based Rabies Vaccine for Humans Manufacturers, Headquarters and Production Site (Province, Country)
        4.5.2 China Based Manufacturers Rabies Vaccine for Humans Production Value (2018-2023)
        4.5.3 China Based Manufacturers Rabies Vaccine for Humans Production (2018-2023)
    4.6 Rest of World Based Rabies Vaccine for Humans Manufacturers and Market Share, 2018-2023
        4.6.1 Rest of World Based Rabies Vaccine for Humans Manufacturers, Headquarters and Production Site (State, Country)
        4.6.2 Rest of World Based Manufacturers Rabies Vaccine for Humans Production Value (2018-2023)
        4.6.3 Rest of World Based Manufacturers Rabies Vaccine for Humans Production (2018-2023)

5 Market Analysis by Type
    5.1 World Rabies Vaccine for Humans Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 Preventative Vaccine
        5.2.2 Emergency Rabies Vaccine
    5.3 Market Segment by Type
        5.3.1 World Rabies Vaccine for Humans Production by Type (2018-2029)
        5.3.2 World Rabies Vaccine for Humans Production Value by Type (2018-2029)
        5.3.3 World Rabies Vaccine for Humans Average Price by Type (2018-2029)

6 Market Analysis by Application
    6.1 World Rabies Vaccine for Humans Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 Pre-exposure prophylaxis
        6.2.2 Post-exposure prophylaxis
    6.3 Market Segment by Application
        6.3.1 World Rabies Vaccine for Humans Production by Application (2018-2029)
        6.3.2 World Rabies Vaccine for Humans Production Value by Application (2018-2029)
        6.3.3 World Rabies Vaccine for Humans Average Price by Application (2018-2029)

7 Company Profiles
    7.1 Novartis
        7.1.1 Novartis Details
        7.1.2 Novartis Major Business
        7.1.3 Novartis Rabies Vaccine for Humans Product and Services
        7.1.4 Novartis Rabies Vaccine for Humans Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.1.5 Novartis Recent Developments/Updates
        7.1.6 Novartis Competitive Strengths & Weaknesses
    7.2 Sanofi
        7.2.1 Sanofi Details
        7.2.2 Sanofi Major Business
        7.2.3 Sanofi Rabies Vaccine for Humans Product and Services
        7.2.4 Sanofi Rabies Vaccine for Humans Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.2.5 Sanofi Recent Developments/Updates
        7.2.6 Sanofi Competitive Strengths & Weaknesses
    7.3 GlaxoSmithKline
        7.3.1 GlaxoSmithKline Details
        7.3.2 GlaxoSmithKline Major Business
        7.3.3 GlaxoSmithKline Rabies Vaccine for Humans Product and Services
        7.3.4 GlaxoSmithKline Rabies Vaccine for Humans Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.3.5 GlaxoSmithKline Recent Developments/Updates
        7.3.6 GlaxoSmithKline Competitive Strengths & Weaknesses
    7.4 Merck
        7.4.1 Merck Details
        7.4.2 Merck Major Business
        7.4.3 Merck Rabies Vaccine for Humans Product and Services
        7.4.4 Merck Rabies Vaccine for Humans Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.4.5 Merck Recent Developments/Updates
        7.4.6 Merck Competitive Strengths & Weaknesses
    7.5 Chengda
        7.5.1 Chengda Details
        7.5.2 Chengda Major Business
        7.5.3 Chengda Rabies Vaccine for Humans Product and Services
        7.5.4 Chengda Rabies Vaccine for Humans Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.5.5 Chengda Recent Developments/Updates
        7.5.6 Chengda Competitive Strengths & Weaknesses
    7.6 Yisheng
        7.6.1 Yisheng Details
        7.6.2 Yisheng Major Business
        7.6.3 Yisheng Rabies Vaccine for Humans Product and Services
        7.6.4 Yisheng Rabies Vaccine for Humans Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.6.5 Yisheng Recent Developments/Updates
        7.6.6 Yisheng Competitive Strengths & Weaknesses
    7.7 Prcmise
        7.7.1 Prcmise Details
        7.7.2 Prcmise Major Business
        7.7.3 Prcmise Rabies Vaccine for Humans Product and Services
        7.7.4 Prcmise Rabies Vaccine for Humans Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.7.5 Prcmise Recent Developments/Updates
        7.7.6 Prcmise Competitive Strengths & Weaknesses
    7.8 VACN
        7.8.1 VACN Details
        7.8.2 VACN Major Business
        7.8.3 VACN Rabies Vaccine for Humans Product and Services
        7.8.4 VACN Rabies Vaccine for Humans Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.8.5 VACN Recent Developments/Updates
        7.8.6 VACN Competitive Strengths & Weaknesses
    7.9 Changsheng
        7.9.1 Changsheng Details
        7.9.2 Changsheng Major Business
        7.9.3 Changsheng Rabies Vaccine for Humans Product and Services
        7.9.4 Changsheng Rabies Vaccine for Humans Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.9.5 Changsheng Recent Developments/Updates
        7.9.6 Changsheng Competitive Strengths & Weaknesses
    7.10 BCHT
        7.10.1 BCHT Details
        7.10.2 BCHT Major Business
        7.10.3 BCHT Rabies Vaccine for Humans Product and Services
        7.10.4 BCHT Rabies Vaccine for Humans Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.10.5 BCHT Recent Developments/Updates
        7.10.6 BCHT Competitive Strengths & Weaknesses
    7.11 Hissen
        7.11.1 Hissen Details
        7.11.2 Hissen Major Business
        7.11.3 Hissen Rabies Vaccine for Humans Product and Services
        7.11.4 Hissen Rabies Vaccine for Humans Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.11.5 Hissen Recent Developments/Updates
        7.11.6 Hissen Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Rabies Vaccine for Humans Industry Chain
    8.2 Rabies Vaccine for Humans Upstream Analysis
        8.2.1 Rabies Vaccine for Humans Core Raw Materials
        8.2.2 Main Manufacturers of Rabies Vaccine for Humans Core Raw Materials
    8.3 Midstream Analysis
    8.4 Downstream Analysis
    8.5 Rabies Vaccine for Humans Production Mode
    8.6 Rabies Vaccine for Humans Procurement Model
    8.7 Rabies Vaccine for Humans Industry Sales Model and Sales Channels
        8.7.1 Rabies Vaccine for Humans Sales Model
        8.7.2 Rabies Vaccine for Humans Typical Customers

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Rabies Vaccine for Humans Production Value by Region (2018, 2022 and 2029) & (USD Million)
    Table 2. World Rabies Vaccine for Humans Production Value by Region (2018-2023) & (USD Million)
    Table 3. World Rabies Vaccine for Humans Production Value by Region (2024-2029) & (USD Million)
    Table 4. World Rabies Vaccine for Humans Production Value Market Share by Region (2018-2023)
    Table 5. World Rabies Vaccine for Humans Production Value Market Share by Region (2024-2029)
    Table 6. World Rabies Vaccine for Humans Production by Region (2018-2023) & (K Units)
    Table 7. World Rabies Vaccine for Humans Production by Region (2024-2029) & (K Units)
    Table 8. World Rabies Vaccine for Humans Production Market Share by Region (2018-2023)
    Table 9. World Rabies Vaccine for Humans Production Market Share by Region (2024-2029)
    Table 10. World Rabies Vaccine for Humans Average Price by Region (2018-2023) & (USD/Unit)
    Table 11. World Rabies Vaccine for Humans Average Price by Region (2024-2029) & (USD/Unit)
    Table 12. Rabies Vaccine for Humans Major Market Trends
    Table 13. World Rabies Vaccine for Humans Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
    Table 14. World Rabies Vaccine for Humans Consumption by Region (2018-2023) & (K Units)
    Table 15. World Rabies Vaccine for Humans Consumption Forecast by Region (2024-2029) & (K Units)
    Table 16. World Rabies Vaccine for Humans Production Value by Manufacturer (2018-2023) & (USD Million)
    Table 17. Production Value Market Share of Key Rabies Vaccine for Humans Producers in 2022
    Table 18. World Rabies Vaccine for Humans Production by Manufacturer (2018-2023) & (K Units)
    Table 19. Production Market Share of Key Rabies Vaccine for Humans Producers in 2022
    Table 20. World Rabies Vaccine for Humans Average Price by Manufacturer (2018-2023) & (USD/Unit)
    Table 21. Global Rabies Vaccine for Humans Company Evaluation Quadrant
    Table 22. World Rabies Vaccine for Humans Industry Rank of Major Manufacturers, Based on Production Value in 2022
    Table 23. Head Office and Rabies Vaccine for Humans Production Site of Key Manufacturer
    Table 24. Rabies Vaccine for Humans Market: Company Product Type Footprint
    Table 25. Rabies Vaccine for Humans Market: Company Product Application Footprint
    Table 26. Rabies Vaccine for Humans Competitive Factors
    Table 27. Rabies Vaccine for Humans New Entrant and Capacity Expansion Plans
    Table 28. Rabies Vaccine for Humans Mergers & Acquisitions Activity
    Table 29. United States VS China Rabies Vaccine for Humans Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 30. United States VS China Rabies Vaccine for Humans Production Comparison, (2018 & 2022 & 2029) & (K Units)
    Table 31. United States VS China Rabies Vaccine for Humans Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
    Table 32. United States Based Rabies Vaccine for Humans Manufacturers, Headquarters and Production Site (States, Country)
    Table 33. United States Based Manufacturers Rabies Vaccine for Humans Production Value, (2018-2023) & (USD Million)
    Table 34. United States Based Manufacturers Rabies Vaccine for Humans Production Value Market Share (2018-2023)
    Table 35. United States Based Manufacturers Rabies Vaccine for Humans Production (2018-2023) & (K Units)
    Table 36. United States Based Manufacturers Rabies Vaccine for Humans Production Market Share (2018-2023)
    Table 37. China Based Rabies Vaccine for Humans Manufacturers, Headquarters and Production Site (Province, Country)
    Table 38. China Based Manufacturers Rabies Vaccine for Humans Production Value, (2018-2023) & (USD Million)
    Table 39. China Based Manufacturers Rabies Vaccine for Humans Production Value Market Share (2018-2023)
    Table 40. China Based Manufacturers Rabies Vaccine for Humans Production (2018-2023) & (K Units)
    Table 41. China Based Manufacturers Rabies Vaccine for Humans Production Market Share (2018-2023)
    Table 42. Rest of World Based Rabies Vaccine for Humans Manufacturers, Headquarters and Production Site (States, Country)
    Table 43. Rest of World Based Manufacturers Rabies Vaccine for Humans Production Value, (2018-2023) & (USD Million)
    Table 44. Rest of World Based Manufacturers Rabies Vaccine for Humans Production Value Market Share (2018-2023)
    Table 45. Rest of World Based Manufacturers Rabies Vaccine for Humans Production (2018-2023) & (K Units)
    Table 46. Rest of World Based Manufacturers Rabies Vaccine for Humans Production Market Share (2018-2023)
    Table 47. World Rabies Vaccine for Humans Production Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 48. World Rabies Vaccine for Humans Production by Type (2018-2023) & (K Units)
    Table 49. World Rabies Vaccine for Humans Production by Type (2024-2029) & (K Units)
    Table 50. World Rabies Vaccine for Humans Production Value by Type (2018-2023) & (USD Million)
    Table 51. World Rabies Vaccine for Humans Production Value by Type (2024-2029) & (USD Million)
    Table 52. World Rabies Vaccine for Humans Average Price by Type (2018-2023) & (USD/Unit)
    Table 53. World Rabies Vaccine for Humans Average Price by Type (2024-2029) & (USD/Unit)
    Table 54. World Rabies Vaccine for Humans Production Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 55. World Rabies Vaccine for Humans Production by Application (2018-2023) & (K Units)
    Table 56. World Rabies Vaccine for Humans Production by Application (2024-2029) & (K Units)
    Table 57. World Rabies Vaccine for Humans Production Value by Application (2018-2023) & (USD Million)
    Table 58. World Rabies Vaccine for Humans Production Value by Application (2024-2029) & (USD Million)
    Table 59. World Rabies Vaccine for Humans Average Price by Application (2018-2023) & (USD/Unit)
    Table 60. World Rabies Vaccine for Humans Average Price by Application (2024-2029) & (USD/Unit)
    Table 61. Novartis Basic Information, Manufacturing Base and Competitors
    Table 62. Novartis Major Business
    Table 63. Novartis Rabies Vaccine for Humans Product and Services
    Table 64. Novartis Rabies Vaccine for Humans Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 65. Novartis Recent Developments/Updates
    Table 66. Novartis Competitive Strengths & Weaknesses
    Table 67. Sanofi Basic Information, Manufacturing Base and Competitors
    Table 68. Sanofi Major Business
    Table 69. Sanofi Rabies Vaccine for Humans Product and Services
    Table 70. Sanofi Rabies Vaccine for Humans Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 71. Sanofi Recent Developments/Updates
    Table 72. Sanofi Competitive Strengths & Weaknesses
    Table 73. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
    Table 74. GlaxoSmithKline Major Business
    Table 75. GlaxoSmithKline Rabies Vaccine for Humans Product and Services
    Table 76. GlaxoSmithKline Rabies Vaccine for Humans Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 77. GlaxoSmithKline Recent Developments/Updates
    Table 78. GlaxoSmithKline Competitive Strengths & Weaknesses
    Table 79. Merck Basic Information, Manufacturing Base and Competitors
    Table 80. Merck Major Business
    Table 81. Merck Rabies Vaccine for Humans Product and Services
    Table 82. Merck Rabies Vaccine for Humans Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 83. Merck Recent Developments/Updates
    Table 84. Merck Competitive Strengths & Weaknesses
    Table 85. Chengda Basic Information, Manufacturing Base and Competitors
    Table 86. Chengda Major Business
    Table 87. Chengda Rabies Vaccine for Humans Product and Services
    Table 88. Chengda Rabies Vaccine for Humans Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 89. Chengda Recent Developments/Updates
    Table 90. Chengda Competitive Strengths & Weaknesses
    Table 91. Yisheng Basic Information, Manufacturing Base and Competitors
    Table 92. Yisheng Major Business
    Table 93. Yisheng Rabies Vaccine for Humans Product and Services
    Table 94. Yisheng Rabies Vaccine for Humans Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 95. Yisheng Recent Developments/Updates
    Table 96. Yisheng Competitive Strengths & Weaknesses
    Table 97. Prcmise Basic Information, Manufacturing Base and Competitors
    Table 98. Prcmise Major Business
    Table 99. Prcmise Rabies Vaccine for Humans Product and Services
    Table 100. Prcmise Rabies Vaccine for Humans Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 101. Prcmise Recent Developments/Updates
    Table 102. Prcmise Competitive Strengths & Weaknesses
    Table 103. VACN Basic Information, Manufacturing Base and Competitors
    Table 104. VACN Major Business
    Table 105. VACN Rabies Vaccine for Humans Product and Services
    Table 106. VACN Rabies Vaccine for Humans Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 107. VACN Recent Developments/Updates
    Table 108. VACN Competitive Strengths & Weaknesses
    Table 109. Changsheng Basic Information, Manufacturing Base and Competitors
    Table 110. Changsheng Major Business
    Table 111. Changsheng Rabies Vaccine for Humans Product and Services
    Table 112. Changsheng Rabies Vaccine for Humans Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 113. Changsheng Recent Developments/Updates
    Table 114. Changsheng Competitive Strengths & Weaknesses
    Table 115. BCHT Basic Information, Manufacturing Base and Competitors
    Table 116. BCHT Major Business
    Table 117. BCHT Rabies Vaccine for Humans Product and Services
    Table 118. BCHT Rabies Vaccine for Humans Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 119. BCHT Recent Developments/Updates
    Table 120. Hissen Basic Information, Manufacturing Base and Competitors
    Table 121. Hissen Major Business
    Table 122. Hissen Rabies Vaccine for Humans Product and Services
    Table 123. Hissen Rabies Vaccine for Humans Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 124. Global Key Players of Rabies Vaccine for Humans Upstream (Raw Materials)
    Table 125. Rabies Vaccine for Humans Typical Customers
    Table 126. Rabies Vaccine for Humans Typical Distributors
List of Figure
    Figure 1. Rabies Vaccine for Humans Picture
    Figure 2. World Rabies Vaccine for Humans Production Value: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World Rabies Vaccine for Humans Production Value and Forecast (2018-2029) & (USD Million)
    Figure 4. World Rabies Vaccine for Humans Production (2018-2029) & (K Units)
    Figure 5. World Rabies Vaccine for Humans Average Price (2018-2029) & (USD/Unit)
    Figure 6. World Rabies Vaccine for Humans Production Value Market Share by Region (2018-2029)
    Figure 7. World Rabies Vaccine for Humans Production Market Share by Region (2018-2029)
    Figure 8. North America Rabies Vaccine for Humans Production (2018-2029) & (K Units)
    Figure 9. Europe Rabies Vaccine for Humans Production (2018-2029) & (K Units)
    Figure 10. China Rabies Vaccine for Humans Production (2018-2029) & (K Units)
    Figure 11. Japan Rabies Vaccine for Humans Production (2018-2029) & (K Units)
    Figure 12. Rabies Vaccine for Humans Market Drivers
    Figure 13. Factors Affecting Demand
    Figure 14. World Rabies Vaccine for Humans Consumption (2018-2029) & (K Units)
    Figure 15. World Rabies Vaccine for Humans Consumption Market Share by Region (2018-2029)
    Figure 16. United States Rabies Vaccine for Humans Consumption (2018-2029) & (K Units)
    Figure 17. China Rabies Vaccine for Humans Consumption (2018-2029) & (K Units)
    Figure 18. Europe Rabies Vaccine for Humans Consumption (2018-2029) & (K Units)
    Figure 19. Japan Rabies Vaccine for Humans Consumption (2018-2029) & (K Units)
    Figure 20. South Korea Rabies Vaccine for Humans Consumption (2018-2029) & (K Units)
    Figure 21. ASEAN Rabies Vaccine for Humans Consumption (2018-2029) & (K Units)
    Figure 22. India Rabies Vaccine for Humans Consumption (2018-2029) & (K Units)
    Figure 23. Producer Shipments of Rabies Vaccine for Humans by Manufacturer Revenue ($MM) and Market Share (%): 2022
    Figure 24. Global Four-firm Concentration Ratios (CR4) for Rabies Vaccine for Humans Markets in 2022
    Figure 25. Global Four-firm Concentration Ratios (CR8) for Rabies Vaccine for Humans Markets in 2022
    Figure 26. United States VS China: Rabies Vaccine for Humans Production Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 27. United States VS China: Rabies Vaccine for Humans Production Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: Rabies Vaccine for Humans Consumption Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. United States Based Manufacturers Rabies Vaccine for Humans Production Market Share 2022
    Figure 30. China Based Manufacturers Rabies Vaccine for Humans Production Market Share 2022
    Figure 31. Rest of World Based Manufacturers Rabies Vaccine for Humans Production Market Share 2022
    Figure 32. World Rabies Vaccine for Humans Production Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 33. World Rabies Vaccine for Humans Production Value Market Share by Type in 2022
    Figure 34. Preventative Vaccine
    Figure 35. Emergency Rabies Vaccine
    Figure 36. World Rabies Vaccine for Humans Production Market Share by Type (2018-2029)
    Figure 37. World Rabies Vaccine for Humans Production Value Market Share by Type (2018-2029)
    Figure 38. World Rabies Vaccine for Humans Average Price by Type (2018-2029) & (USD/Unit)
    Figure 39. World Rabies Vaccine for Humans Production Value by Application, (USD Million), 2018 & 2022 & 2029
    Figure 40. World Rabies Vaccine for Humans Production Value Market Share by Application in 2022
    Figure 41. Pre-exposure prophylaxis
    Figure 42. Post-exposure prophylaxis
    Figure 43. World Rabies Vaccine for Humans Production Market Share by Application (2018-2029)
    Figure 44. World Rabies Vaccine for Humans Production Value Market Share by Application (2018-2029)
    Figure 45. World Rabies Vaccine for Humans Average Price by Application (2018-2029) & (USD/Unit)
    Figure 46. Rabies Vaccine for Humans Industry Chain
    Figure 47. Rabies Vaccine for Humans Procurement Model
    Figure 48. Rabies Vaccine for Humans Sales Model
    Figure 49. Rabies Vaccine for Humans Sales Channels, Direct Sales, and Distribution
    Figure 50. Methodology
    Figure 51. Research Process and Data Source